Contract Research Organization for dermatology and rheumatology clinical trials
Indero operates a dual-focus CRO built around dermatology and rheumatology Phase I–IV trials, leveraging 25+ years of domain expertise. The tech stack—Medidata Rave, Veeva CDMS, SAS, Azure infrastructure—reflects standard pharma clinical ops, but the active hiring mix (56 research roles against 8 legal, 8 ops, 4 regulatory) and current project list (site activation, global Phase III, CDISC/SDTM validation) signal aggressive capacity scaling across trial execution rather than platform innovation.
Indero is a Montreal-based Contract Research Organization specializing in dermatology and rheumatology clinical development. Founded in 2000, the company operates across 201–500 employees with a service offering spanning study design, regulatory consulting, site selection, patient recruitment, clinical monitoring, pharmacovigilance, data management, biostatistics, and medical writing. The organization delivers Phase I through IV trials and maintains clinical research sites. Hiring activity is concentrated across Canada, the United States, and nine additional countries (Poland, Brazil, Spain, Romania, Germany, India, Argentina); the accelerating recruitment velocity indicates expansion of trial delivery capacity.
Indero conducts Phase I, II, III, and IV clinical trials, with current projects including global Phase III programs. The company serves as both a full-service CRO and operates clinical research sites.
Indero's stack includes Medidata Rave for clinical trial management, Veeva CDMS for data management, SAS for biostatistics, and CDISC standards (SDTM, ADaM) for data validation and exchange.
Indero (formerly Innovaderm)'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.